I dont share targets on ODX as I believe that LFT as diagnostic tools will take off over the next 5 years and I intend to hold my shares for that timeframe.
I also see ODX as a key player in the reinvigorating of UK diagnostics. If the COV antigen test takes off and profits are reinvested for further targets of concern I see multiple pounds in the future.
Although a positive RNS I feel AIM traders dont have the attention span to wait for the future gains so I think 53 to 54p finish today but maintain a very rosy outlook.
The whole asylum turned up today. I just wonder why this terrible company gets so much attention from the Eeyore crew. Wouldnt you think they would be better off invested elsewhere.
Thinkin I think I'm possibly more informed of the vagaries of navigating selling diagnostic products so therefore not liable to only post negatively on the share board of a company that's transformed itself within 2 years and is only being held back by political decisions.
I see the ODX journey since I invested in March 2020 as largely positive and am naturally suspicious of anyone who never posts a positive view. Even twatcher, who in my opinion is actually overly vilified here , posts positively when they see news of note.
RE: The biosure home antibody test27 Aug 2021 16:54
They have to be subcontracting work. There is no way on earth an 11 person company has developed, verified, validated, CE marked, sought self test approval and marketed an IVD.
Well this is all very exciting. Not hearing too much from our collection of miserable 8am witherspoon guineas drinkers today. Well except from shelley who appears to have either had an experimental perso amity transplant or enough MDMA to supply creamfields for the weekend